공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 천식 치료제 시장 : 제품별(장기적 질병 조절제, 알레르기 유발성 천식 치료제, 속효성 증상 완화제), 용도별 시장 조사, 예측(-2025년), COVID-19의 누적 영향

Asthma Drugs Market Research Report by Product (Long-term control medications, Medications for allergy-induced asthma, and Quick-relief medications ), by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19

리서치사 360iResearch LLP
발행일 2021년 04월 상품 코드 1000968
페이지 정보 영문 184 Pages
가격
US $ 3,949 ₩ 4,531,000 Online Access (Single User License - 1 Year)
US $ 4,949 ₩ 5,678,000 PDF (Single User License) + Excel
US $ 5,949 ₩ 6,826,000 PDF (1-5 User License) + Excel
US $ 7,949 ₩ 9,121,000 PDF (Site License) + Excel
US $ 9,949 ₩ 11,416,000 PDF (Enterprise License) + Excel


세계의 천식 치료제 시장 : 제품별(장기적 질병 조절제, 알레르기 유발성 천식 치료제, 속효성 증상 완화제), 용도별 시장 조사, 예측(-2025년), COVID-19의 누적 영향 Asthma Drugs Market Research Report by Product (Long-term control medications, Medications for allergy-induced asthma, and Quick-relief medications ), by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19
발행일 : 2021년 04월 페이지 정보 : 영문 184 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 천식 치료제 시장 규모는 2020년 148억 3,758만 달러에서 2025년 말까지 213억 8,279만 달러로 성장할 것으로 예상됩니다.

COVID-19는 미증유의 세계적인 공중위생상 긴급사태이며, 모든 업계에 영향을 미쳐 왔습니다. 이 장기적 영향은 예측기간 중 업계의 성장에 영향을 미칠 것으로 예측됩니다. 우리가 진행하고 있는 조사에서는 기저에 있는 COVID-19의 문제와 향후 방향을 확실히 다루기 위해 조사 범위를 확대시키고 있습니다. 소비자의 행동과 수요 변화, 구입 패턴, 공급망 재라우팅, 현재 시장 동향 및 정부의 중요한 개입 등을 고려하면서, COVID-19에 대한 인사이트를 제공합니다. 업데이트된 조사에서는 COVID-19가 시장에 미치는 영향을 고려하고, 인사이트, 분석, 예측 등을 제공합니다.

세계의 천식 치료제(Asthma Drugs) 시장에 대해 조사했으며, 시장 개요와 함께 제품별, 용도별, 지역별 동향, COVID-19의 누적 영향 및 시장에 참여하는 기업 개요 등을 제공합니다.

목차

제1장 서문

  • 조사 목적
  • 시장 세분화와 범위
  • 조사 대상 연도
  • 통화와 가격
  • 언어
  • 제한
  • 이해관계자

제2장 조사 방법

  • 조사 과정
    • 정의 : 조사 목적
    • 결정 : 조사 디자인
    • 준비 : 조사 기기
    • 수집 : 데이터 소스
    • 분석 : 데이터 해석
    • 책정 : 데이터 검증
    • 공개 : 조사 보고서
    • 반복 : 보고서 갱신
  • 조사 실행
    • 개시 : 조사 과정
    • 계획 : 조사 계획 작성
    • 실행 : 조사 실시
    • 검증 : 발견과 분석
    • 출판물 : 조사 보고
  • 조사 성과

제3장 주요 요약

  • 서론
  • 시장 전망
  • 제품별 전망
  • 용도별 전망
  • 지역별 전망
  • 경쟁사별 전망

제4장 시장 개요

  • 서론
  • COVID-19의 누적 영향

제5장 시장 인사이트

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
    • 과제
  • Porters Five Forces 분석
    • 신규 참여업체의 위협
    • 대체품의 위협
    • 고객의 협상력
    • 공급 기업의 협상력
    • 업계의 경쟁

제6장 세계의 천식 치료제 시장, 제품별

  • 장기적 질병 조절제
  • 알레르기 유발성 천식 치료제
  • 속효성 증상 완화제(구조약물)

제7장 세계의 천식 치료제 시장, 용도별

  • 병원 약국
  • 온라인 약국
  • 소매 약국

제8장 아메리카의 천식 치료제시장

  • 아르헨티나
  • 브라질
  • 캐나다
  • 멕시코
  • 미국

제9장 아시아태평양의 천식 치료제 시장

  • 호주
  • 중국
  • 인도
  • 인도네시아
  • 일본
  • 말레이시아
  • 필리핀
  • 한국
  • 태국

제10장 유럽, 중동 및 아프리카의 천식 치료제 시장

  • 프랑스
  • 독일
  • 이탈리아
  • 네덜란드
  • 카타르
  • 러시아
  • 사우디아라비아
  • 남아프리카공화국
  • 스페인
  • 아랍에미리트
  • 영국

제11장 경쟁 상황

  • FPNV 포지셔닝 매트릭스
    • 상한
    • 사업 전략
    • 제품 만족도
  • 시장 순위 분석
  • 시장 점유율 분석
  • 경쟁사 SWOT 분석
  • 경쟁 시나리오
    • 합병과 인수
    • 합의, 협업 및 파트너십
    • 신제품 발매와 강화
    • 투자와 자금 조달
    • 상, 표창, 확대

제12장 기업 유저빌리티 개요

  • Aerocrine(Circassia)
  • ALK-Abello A/S
  • Amphastar Pharmaceuticals, Inc.
  • AstraZeneca
  • Boehringer Ingelheim
  • Camber Pharmaceuticals
  • Chiesi Farmaceutici
  • Cipla
  • Cohero Health
  • GlaxoSmithKline PLC
  • Inspiro Medical(Opko Health)
  • Lallemand Pharma International
  • Merck & Co., Inc.
  • MundiPharma
  • Novartis AG
  • Pulmatrix
  • Roche Holding AG
  • Sanner GmbH
  • Sanofi/Regeneron
  • Sunovion
  • Teva
  • Theravance Biopharma|Mylan Inc.
  • Vectura Group plc
  • Verona Pharma plc

제13장 부록

  • 논의 가이드
  • 라이선스와 가격
KSM 21.04.27

LIST OF FIGURES

  • FIGURE 1. GLOBAL ASTHMA DRUGS MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL ASTHMA DRUGS MARKET: RESEARCH EXECUTION
  • FIGURE 3. GLOBAL ASTHMA DRUGS MARKET SIZE, 2020 VS 2025 (USD MILLION)
  • FIGURE 4. GLOBAL ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 7. GLOBAL ASTHMA DRUGS MARKET SIZE, 2018-2025 (USD MILLION)
  • FIGURE 8. GLOBAL ASTHMA DRUGS MARKET: MARKET DYNAMICS
  • FIGURE 9. GLOBAL ASTHMA DRUGS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 10. GLOBAL ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2020 VS 2025 (%)
  • FIGURE 11. GLOBAL ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2020 VS 2025 (USD MILLION)
  • FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2025
  • FIGURE 13. GLOBAL ASTHMA DRUGS MARKET SIZE, BY LONG-TERM CONTROL MEDICATIONS, 2020 VS 2025 (USD MILLION)
  • FIGURE 14. GLOBAL ASTHMA DRUGS MARKET SIZE, BY MEDICATIONS FOR ALLERGY-INDUCED ASTHMA, 2020 VS 2025 (USD MILLION)
  • FIGURE 15. GLOBAL ASTHMA DRUGS MARKET SIZE, BY QUICK-RELIEF MEDICATIONS (RESCUE MEDICATIONS), 2020 VS 2025 (USD MILLION)
  • FIGURE 16. GLOBAL ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
  • FIGURE 17. GLOBAL ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
  • FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2025
  • FIGURE 19. GLOBAL ASTHMA DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2020 VS 2025 (USD MILLION)
  • FIGURE 20. GLOBAL ASTHMA DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2020 VS 2025 (USD MILLION)
  • FIGURE 21. GLOBAL ASTHMA DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2020 VS 2025 (USD MILLION)
  • FIGURE 22. AMERICAS ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 23. AMERICAS ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 25. ARGENTINA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 26. BRAZIL ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 27. CANADA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 28. MEXICO ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 29. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 30. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 31. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 33. AUSTRALIA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 34. CHINA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 35. INDIA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 36. INDONESIA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 37. JAPAN ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 38. MALAYSIA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 39. PHILIPPINES ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 40. SOUTH KOREA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 41. THAILAND ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 42. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 43. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 44. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 45. FRANCE ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 46. GERMANY ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 47. ITALY ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 48. NETHERLANDS ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 49. QATAR ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 50. RUSSIA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 51. SAUDI ARABIA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 52. SOUTH AFRICA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 53. SPAIN ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 54. UNITED ARAB EMIRATES ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 55. UNITED KINGDOM ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 56. GLOBAL ASTHMA DRUGS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 57. GLOBAL ASTHMA DRUGS MARKET: MARKET SHARE ANALYSIS
  • FIGURE 58. GLOBAL ASTHMA DRUGS MARKET: COMPETITOR SWOT ANALYSIS
  • FIGURE 59. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ASTHMA DRUGS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. CURRENCY CONVERSION RATES
  • TABLE 2. GLOBAL ASTHMA DRUGS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 3. GLOBAL ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL ASTHMA DRUGS MARKET SIZE, BY LONG-TERM CONTROL MEDICATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL ASTHMA DRUGS MARKET SIZE, BY MEDICATIONS FOR ALLERGY-INDUCED ASTHMA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL ASTHMA DRUGS MARKET SIZE, BY QUICK-RELIEF MEDICATIONS (RESCUE MEDICATIONS), BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL ASTHMA DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL ASTHMA DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL ASTHMA DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. AMERICAS ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. AMERICAS ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. AMERICAS ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. ARGENTINA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. ARGENTINA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. BRAZIL ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. BRAZIL ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. CANADA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. CANADA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. MEXICO ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. MEXICO ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. AUSTRALIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. AUSTRALIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. CHINA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. CHINA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. INDIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. INDIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. INDONESIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. INDONESIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. JAPAN ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. JAPAN ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. MALAYSIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. MALAYSIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. PHILIPPINES ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. PHILIPPINES ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. SOUTH KOREA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. SOUTH KOREA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. THAILAND ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. THAILAND ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. FRANCE ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. FRANCE ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. GERMANY ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. GERMANY ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. ITALY ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. ITALY ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. NETHERLANDS ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. NETHERLANDS ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. QATAR ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. QATAR ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. RUSSIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. RUSSIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. SAUDI ARABIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. SAUDI ARABIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. SOUTH AFRICA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. SOUTH AFRICA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. SPAIN ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. SPAIN ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. UNITED ARAB EMIRATES ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. UNITED ARAB EMIRATES ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. UNITED KINGDOM ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. UNITED KINGDOM ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. GLOBAL ASTHMA DRUGS MARKET: SCORES
  • TABLE 71. GLOBAL ASTHMA DRUGS MARKET: BUSINESS STRATEGY
  • TABLE 72. GLOBAL ASTHMA DRUGS MARKET: PRODUCT SATISFACTION
  • TABLE 73. GLOBAL ASTHMA DRUGS MARKET: RANKING
  • TABLE 74. GLOBAL ASTHMA DRUGS MARKET: MERGER & ACQUISITION
  • TABLE 75. GLOBAL ASTHMA DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 76. GLOBAL ASTHMA DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 77. GLOBAL ASTHMA DRUGS MARKET: INVESTMENT & FUNDING
  • TABLE 78. GLOBAL ASTHMA DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 79. GLOBAL ASTHMA DRUGS MARKET: LICENSE & PRICING

Title:
Asthma Drugs Market Research Report by Product (Long-term control medications, Medications for allergy-induced asthma, and Quick-relief medications (rescue medications)), by Application (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy) - Global Forecast to 2025 - Cumulative Impact of COVID-19.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Asthma Drugs Market is expected to grow from USD 14,837.58 Million in 2020 to USD 21,382.79 Million by the end of 2025.

2. The Global Asthma Drugs Market is expected to grow from EUR 13,009.87 Million in 2020 to EUR 18,748.83 Million by the end of 2025.

3. The Global Asthma Drugs Market is expected to grow from GBP 11,565.80 Million in 2020 to GBP 16,667.75 Million by the end of 2025.

4. The Global Asthma Drugs Market is expected to grow from JPY 1,583,545.77 Million in 2020 to JPY 2,282,085.53 Million by the end of 2025.

5. The Global Asthma Drugs Market is expected to grow from AUD 21,546.13 Million in 2020 to AUD 31,050.65 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Asthma Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Asthma Drugs Market studied across Long-term control medications, Medications for allergy-induced asthma, and Quick-relief medications (rescue medications).

Based on Application, the Asthma Drugs Market studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.

Based on Geography, the Asthma Drugs Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Asthma Drugs Market including Aerocrine (Circassia), ALK-Abello A/S, Amphastar Pharmaceuticals, Inc., AstraZeneca, Boehringer Ingelheim, Camber Pharmaceuticals, Chiesi Farmaceutici, Cipla, Cohero Health, GlaxoSmithKline PLC, Inspiro Medical (Opko Health), Lallemand Pharma International, Merck & Co., Inc., MundiPharma, Novartis AG, Pulmatrix, Roche Holding AG, Sanner GmbH, Sanofi/Regeneron, Sunovion, Teva, Theravance Biopharma|Mylan Inc., Vectura Group plc, and Verona Pharma plc.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch™FPNV Positioning Matrix:

The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Asthma Drugs Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch™Competitive Strategic Window:

The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Asthma Drugs Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Asthma Drugs Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Asthma Drugs Market?

4. What is the competitive strategic window for opportunities in the Global Asthma Drugs Market?

5. What are the technology trends and regulatory frameworks in the Global Asthma Drugs Market?

6. What are the modes and strategic moves considered suitable for entering the Global Asthma Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Define: Research Objective
    • 2.1.2. Determine: Research Design
    • 2.1.3. Prepare: Research Instrument
    • 2.1.4. Collect: Data Source
    • 2.1.5. Analyze: Data Interpretation
    • 2.1.6. Formulate: Data Verification
    • 2.1.7. Publish: Research Report
    • 2.1.8. Repeat: Report Update
  • 2.2. Research Execution
    • 2.2.1. Initiation: Research Process
    • 2.2.2. Planning: Develop Research Plan
    • 2.2.3. Execution: Conduct Research
    • 2.2.4. Verification: Finding & Analysis
    • 2.2.5. Publication: Research Report
  • 2.3. Research Outcome

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Product Outlook
  • 3.4. Application Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of asthma globally
      • 5.1.1.2. Increasing acceptance of asthma drugs with approval from FDA
      • 5.1.1.3. Government initiatives fuels the awareness of asthma drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Expiry of patent drugs and high penetration of generic drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in the development of asthma drugs
      • 5.1.3.2. Introduction of generic drugs in developing regions
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent government regulations for the approval of asthma drugs
  • 5.2. Porters Five Forces Analysis
    • 5.2.1. Threat of New Entrants
    • 5.2.2. Threat of Substitutes
    • 5.2.3. Bargaining Power of Customers
    • 5.2.4. Bargaining Power of Suppliers
    • 5.2.5. Industry Rivalry

6. Global Asthma Drugs Market, By Product

  • 6.1. Introduction
  • 6.2. Long-term control medications
  • 6.3. Medications for allergy-induced asthma
  • 6.4. Quick-relief medications (rescue medications)

7. Global Asthma Drugs Market, By Application

  • 7.1. Introduction
  • 7.2. Hospital Pharmacy
  • 7.3. Online Pharmacy
  • 7.4. Retail Pharmacy

8. Americas Asthma Drugs Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Asthma Drugs Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. South Korea
  • 9.10. Thailand

10. Europe, Middle East & Africa Asthma Drugs Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis
  • 11.4. Competitor SWOT Analysis
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Aerocrine (Circassia)
  • 12.2. ALK-Abello A/S
  • 12.3. Amphastar Pharmaceuticals, Inc.
  • 12.4. AstraZeneca
  • 12.5. Boehringer Ingelheim
  • 12.6. Camber Pharmaceuticals
  • 12.7. Chiesi Farmaceutici
  • 12.8. Cipla
  • 12.9. Cohero Health
  • 12.10. GlaxoSmithKline PLC
  • 12.11. Inspiro Medical (Opko Health)
  • 12.12. Lallemand Pharma International
  • 12.13. Merck & Co., Inc.
  • 12.14. MundiPharma
  • 12.15. Novartis AG
  • 12.16. Pulmatrix
  • 12.17. Roche Holding AG
  • 12.18. Sanner GmbH
  • 12.19. Sanofi/Regeneron
  • 12.20. Sunovion
  • 12.21. Teva
  • 12.22. Theravance Biopharma|Mylan Inc.
  • 12.23. Vectura Group plc
  • 12.24. Verona Pharma plc

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
Back to Top
전화 문의
F A Q